Showing results (3041-3050 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|December 9, 2020
Phase I Study of Afatinib and Selumetinib in Patients with KRAS-Mutated Colorectal, Non-Small Cell Lung, and Pancreatic CancerEmilie M J van Brummelen, Sanne Huijberts, Carla van Herpen, et al.
The Oncologist|December 4, 2020
Prediction and Prevention of Cancer-Associated ThromboembolismAlok A Khorana, Maria T DeSancho, Howard Liebman, et al.
The Oncologist|December 7, 2020
Timing of Palliative Care Referral Before and After Evidence from Trials Supporting Early Palliative CareDavid Hausner, Colombe Tricou, Jean Mathews, et al.
The Oncologist|October 26, 2020
Emerging Immunotherapies in the Treatment of Brain MetastasesEdwin Nieblas-Bedolla, Naema Nayyar, Mohini Singh, et al.
The Oncologist|December 1, 2018
Patient Navigation to Enhance Access to Care for Underserved Patients with a Suspicion or Diagnosis of CancerYanin Chavarri-Guerra, Enrique Soto-Perez-de-Celis, Wendy Ramos-López, et al.
The Oncologist|December 21, 2017
Racial and Ethnic Composition of Cancer Clinical Drug Trials: How Diverse Are We?Leslie J Dickmann, Jennifer L Schutzman
The Oncologist|November 29, 2018
High-Grade Gastrointestinal Neuroendocrine Carcinoma Management and Outcomes: A National Cancer Database StudyOlatunji B Alese, Renjian Jiang, Walid Shaib, et al.
The Oncologist|March 8, 2018
A First-in-Human Phase I Study of OPB-111077, a Small-Molecule STAT3 and Oxidative Phosphorylation Inhibitor, in Patients with Advanced CancersAnthony Tolcher, Keith Flaherty, Geoffrey I Shapiro, et al.
The Oncologist|December 8, 2018
Patient-Centered Oncology or Population-Centered Oncology-Which Do We Want, and Which Tradeoffs Are We Willing To Accept?Daniel A Goldstein, Robert B Den
The Oncologist|December 17, 2013
Advancing cervical cancer prevention in India: implementation science prioritiesSuneeta Krishnan, Emily Madsen, Deborah Porterfield, et al.
Pageof 571